Ligand Pharma (LGND) PT Lowered to $85 at Roth Capital
Tweet Send to a Friend
Roth Capital analyst Scott Henry ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
